poisar

Stocks · News reference

Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back

Chandrima Sanyal

JPMorgan sees healthcare ETF flows reversing, with Eli Lilly and AbbVie among stocks that could benefit from renewed sector rotation.

More stocks newsConnected markets

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

ABBVGLDJNJLLYMRKVHTXBIXLV
Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Delveinsight

    Global Dermatological Therapeutics Market to Reach USD 97 Billion by 2034 | DelveInsight

    The global dermatological therapeutics market is projected to grow from USD 43 billion in 2025 to USD 97 billion by 2034, with a CAGR of approximately 10%. Growth is driven by rising prevalence of chronic skin disorders, adoption of biologics and JAK inhibitors, increased healthcare spending, and growing awareness of skin health. North America leads the market with 46% share, while Asia-Pacific is expected to register the fastest growth.

    ABBVLLYJNJNVSBMY
  3. Arcutis Biotherapeutics, Inc.

    Arcutis Appoints Rob Scott, MD to Board of Directors

    Arcutis Biotherapeutics announced the appointment of Dr. Rob Scott, a veteran pharma executive with over 40 years of experience, to its Board of Directors effective October 23, 2026. Dr. Scott, formerly Chief Medical Officer at AbbVie, brings extensive expertise in drug development and regulatory approvals. The company highlighted strong adoption of its ZORYVE product and a growing pipeline of new indications and novel biologics.

    ARQTABBV